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The first steps in leishmaniasis are critical in determining the evolution of the disease. Major advances have
recently been done in understanding this crucial moment. Fundamental research in parasite-vector interaction,
parasite biology, insect saliva, and vertebrate host response have shed new light and uncovered a most fascinating
and complex moment in leishmaniasis. We review here some of these aspects and we try to connect them in a logical
framework.
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 Leishmaniasis is a serious and sometimes fatal disease
causing much suffering in human beings. However, from
the strict biological point of view, man can be seen as just
one of the actors of the drama. The others are the parasite,
the insect, and the double: the mouse.
 In the initial scenario of human leishmaniasis there
are then three central players: the parasite, the insect, and
the human being. The biological conversation among
these players evolves dynamically. The initial steps are
fundamental in determining the fate of drama or disease.
In most of these crucial moments, due to ethical im-
peratives, the mouse double comes in scene. Thus, the
initial steps of Leishmania infection in humans are really
largely unknown. We try to infer from the subtleties of the
conversation what will happen in the next act.
We must, however, be sure that chance and actors’
hidden strategies could radically change our deterministic
thought. Finally, the double could not act exactly as the
man.
THE PARASITE AND THE INSECT
The genus Leishmania, a group of protozoan
flagellates of the family Trypanosomatidae, order
Kinetoplastida, has two morphological forms in its lifecycle
– the amastigotes and the promastigotes. The amastigotes
live inside lisossomal vacuoles present in phagocytic
cells of the vertebrate host, namely monocytes and ma-
crophages, which are ingested by the female phle-
botomine sand fly when it takes an infecting bloodmeal
(Lainson et al. 1987, Chang et al. 1990, Alexander et al.
1999). Once in the insect midgut the parasite transforms
into the promastigote, the extracelular form, which may be
found free or attached to the intestinal cuticle or microvilli
(Walters et al. 1989a, b,  Killick-Kendrick 1990a).
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Diptera of the subfamily Phlebotominae are the only
vectors of the various Leishmania species, with the genus
Phlebotomus hosting the Old World species and
Lutzomyia the species of the New World (Shaw & Lainson
1987, Killick-Kendrick 1990b). In these blood-sucking
insects the parasite develops a complex series of mor-
phological (Adler & Theodor 1931, Walters et al. 1989a, b,
Killick-Kendrick 1990a) and functional (Sacks 1989)
modifications. Shortly, the parasite differentiates from a
dividing procyclic promastigote stage that avoids
expulsion from the midgut by attaching to the gut wall, to
a nondividing metacyclic promastigote stage that is unable
to attach to the midgut and migrates to the mouth parts
(Adler & Theodor 1931, Killick-Kendric 1987, Walters et
al. 1989a, b , Killick-Kendrick 1990a, Pimenta et al. 1992,
Mahoney et al. 1999). Sacks and Perkins (1985) reported,
for example, that clones of L. (L.) amazonensis in Lu.
longipalpis were not able to infect BALB/c mice when
inoculation was carried out 3 days after the insect’s in-
fection, but the inoculum became progressively infective
from the 4th until the 7th day of development in the sand
fly midgut. Coincidentally, the maximum infective capacity
occurs at the time of a new bloodmeal. When the infected
phlebotomine probes a new host, it regurgitates about 1
to 1000 metacyclics, closing the life cycle (Adler & Theodor
1935, Warburg & Schlein 1986). It seems clear that this
coordination of events takes the parasite to an optimum
opportunity to infect the vertebrate host and perpetuate
its cycle.
THE HOST RESPONSE
When the haematophagous insect bites a vertebrate
host (Figs 1, 2) it introduces its mouthparts into the skin,
lacerates blood vessels causing hemorrhages and then
feeds in the haemorrhagic pool formed (Ribeiro 1987). In
the generation of leishmaniasis primeval blood lake not
only the mechanical action of insect probocis but also
enzymatic action of insect saliva, hyaluronidase (Charlab
et al. 1999) for example, could be acting. This is a complex
interaction. It was described that the site of inoculation
(dermal or subcutaneous) influences the development of
the lesion (Poulter & Pandolph 1982, Nicolas et al. 2000).
In this particular situation, the short length of the
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phlebotomine proboscis determines that only the
superficial vessels of the dermis, at the dermal-epidermal
interface, can be reached. Without the vasodilator activity
of its saliva, the sand fly would hardly achieve the dermal
capillaries (Ribeiro et al. 1984). At this point, a battle takes
place between the host resistance and the insect’s
strategies to obtain blood. At the host’s side, the natural
defense mechanisms will be activated due to the presence,
at the site of inoculation, of agents like complement system,
thrombin, kinins, platelets, natural antibodies, phagocytes,
etc. By the vector’s side, the pharmacological agents of
the saliva are maxadilan, adenosine, interleukin 2 (IL-2)
binding factor, apyrase, prostaglandins, etc. (Ribeiro 1987,
Gillespie et al. 2000). This scenario, where the players will
act for the first time, will determine the course of the host-
parasite relationship. It was demonstrated, for example,
that in mice inoculated with a mixture of phlebotomine
saliva and L. (L.) major promastigotes, the lesions grew
faster and were bigger than those of mice inoculated only
with promastigotes (Belkaid et al. 1998). The host capacity
of immediate response to this aggression through the
kinins (vasoconstriction), coagulation (thrombosis), and
phagocytic-neutrophilic systems, could decrease the
vectorial competence, hampering or even preventing the
insect ability to blood-feed (Gillespie et al. 2000). However,
the sand fly saliva has potent vasodilatatory agents,
maxadilan (Lutzomyia) (Lerner et al. 1991) and adenosyne
(Phlebotomus) (Ribeiro et al. 1999), antiplatetelet
aggregation, apyrase (Lutzomyia and Phlebotomus)
(Valenzuela et al. 2001), and prostaglandin E2 (vaso-
dilatatory and immunossupressive actions) (Reiner et al.
1987, Lonardoni et al. 2000) production stimulators (Soares
et al. 1998), that counterbalance this response. In general,
the vectorial strategy of inhibiting host coagulation
system, as host procoagulant and inflammatory response
are closely linked (Bernard et al. 2001), reduces the host
sensitization and inflammation, both of major importance
for parasite transmission (Gillespie et al. 2000). It has been
shown, for example, that the previous sensitization of mice
with P. papatasii sonicated salivary glands is capable of
eliminating the enhancing effects of saliva on L. (L.) major
infection, notably the precocious epidermal generation of
IL-4 and IL-5 (Belkaid et al. 1998). However, in an apparent
case of conflict of interests, P. papatasii, due to increased
blood flow in inflamatory area, benefits from induced host
delayed type hypersensivity response (Belkaid et al. 2000).
Strong correlation has been also found between delayed
type hypersensivity response to Leishmania antigens and
anti-salivary gland IgG1 and IgE levels from children living
in endemic areas of visceral leishmaniasis (Barral et al.
2000, Gomes et al. 2002). Thus, previous non-infected
phlebotomine bites may confer a degree of protection
against infection (Kamhawi 2000). Effective vaccination
approaches able to protecting the host against Leishmania
infection, using maxadilan (Morris et al. 2001) or other
protective proteins in the insect saliva (Valenzuela et al.
2001), have been reported in mice.
In a subsequent moment, the establishment of a T-
helper (TH) 1 response which protects against intracellular
pathogens, or a TH2 host response that is linked to allergy
or protection against extracellular pathogens, will be
essential for the control (resistance) or, on the other side,
the more or less intense development of the infection
(Reiner & Locksley 1995).
Basically, three hypothesis have been proposed for
explaining the TH1/TH2 imbalance in experimental
leishmaniasis (Reiner & Locksley 1995): (1) different
peptides stimulate distinct groups of TH1 or TH2 clones,
(2) a particular pattern of cytokines and cofactors,
produced by innate immune system accessory cells, would
be the reason for the divergence, (3) under stimulation, T
cells of different mice strains would have an innate
tendency for the development of one of the two poles of
the response (clones of T cells derived from C57BL/6 mice
for example, would take the TH1 direction while cells from
BALB/c would go for the TH2 pole). Reinforcing the first
hypothesis, a LACK (Leishmania homologue of mam-
malian receptors for activated C kinase 1) peptide was
identified in L. major which, recognized by BALB/c
Vβ4Vα8 CD4+ cells, induces IL-4 secretion by these cells
12 to 14 h after infection, driving the immune response to
the TH2 side (Launois et al. 1997, 1999). However, this
response can be changed to the TH1 side with low antigen
dose (Menon & Bretscher 1998), early presence of IL-12
or IFN-γ (Scott 1991, Scharton-Kersten & Scott 1995,
Doherty & Coffman 1996) or IL-4 injection in the first 12 h
of infection (Himmelrich et al. 2000, Biedermann et al.
2001). Notwithstanding, it is controversial whether the
cytokines that induce TH1 or TH2 differentiation instruct
the development of naïve T helper cells or select from
previous committed TH1 or TH2 cells (Coffman & Reiner
1999). It was thought that a divergent production of IL-12
by dendritic cells of BALB/c and C57BL/6 mice could
explain the TH1 and TH2 response in these mice (von
Stebut et al. 1998). Afterwards it was found that dendritic
cells of both lineages were able to produce IL-12 in
Fig. 1: illustration of a phlebotominie bitting in a superficial dermal
vessel.
863Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 98(7), October 2003
response to L. major infection (von Stebut et al. 2000).
So far it has been given more emphasis in searching
peptides that, recognized by the adaptative immune
system, will direct the immune response to the TH1 or
TH2 side. Recently, however, it has been shown that a
recombinant leishmanial protein, a homologue of
eukaryotic ribosomal elongation and initiation factor 4a
(LeIF), induces the production of IL-12 and IL-18 by APC
cells (Skeiky et al. 1998, Borges et al. 2001). LeIF also
directs the adaptative immune response to the TH1 side
in BALB/c mice (Skeiky et al. 1998). Moreover, contrary to
previously held beliefs, due to IL-12 action, LeIF converts
TH2 cell populations from L. (L.) major infected BALB/c
mice to IFN-γ producers (Skeiky et al. 1998). These findings
expand the classical group of the so called pathogen-
associated molecular patterns (PAMP), mainly applicable
to homopolymers that are integral components of bacterial
and fungal cell walls (Borges et al. 2001). The classical
PAMP group includes: LPS, peptidoglycan, lipoteichoic
acid, mannans, bacterial DNA, double strand RNA, and
glucans (Medzhitov & Janeway 2000). The PAMP are
recognized in the host by pattern-recognition receptors
(PRR). These receptors are chiefly present in APC cells
as, for example, monocytes, macrophages, B cells,
dendritic cells (Medzhitov & Janeway 2000) and
neutrophils (Hayashi et al. 2003). Toll-like receptors allow
immediate effector cell response upon PAMP recognition.
Leishmania, with its characteristic down modulating
effects on monocytes/macrophages (see below), seems
to avoid or overcome this immediate response. Accor-
dingly, L. (L.) major was shown to induce the transcription
of IL-1α through an adapter protein, MyD88 (myeloid
differentiation factor 88), known to interact with Toll-like
receptors (Hawn et al. 2002). Hence, signaling pathways
of Toll-like receptors are involved in the inflammatory
response to Leishmania infection. On the other hand,
Leishmania had inhibitory effects acting on RNA
transcription and translation, as RNA levels in infected
macrophages were lower than controls, and no protein
was detected in supernatants (Hawn et al. 2002).
Leishmania does not have a true cellular wall, but it has
an analogous structure, its LPG coat, fully developed in
metacyclic forms (Pimenta et al. 1991). LPG molecules from
both procyclics and metacyclics were found to directly
activate NK cells through Toll-like receptor-2 (Becker et
al. 2003). Interestingly, L. major metacyclic LPG had a more
intense stimulatory effect than procyclic LPG. Both IFN-γ
and TNF-α were detected in culture supernatants of
stimulated cells (Becker et al. 2003). Therefore, IFN-γ
production by NK cells could be via IL-12 and IL-18,
derived from PAMP stimulated APC cells (Borges et al.
2001), or directly by PAMP binding to its own PRR in NK
cells (Becker et al. 2003). The recent report of NK1 and
NK2 subsets reminiscent of TH1 and TH2 cells (Peritt et
al. 1998), and the findings of  Borges et al. (2001) and
Becker et al. (2003), address an important role for NK cells
at the initial phases of Leishmania infection – that of im-
munomodulatory cells.
 It seems thus clear that the pattern of innate immunity
at the initial phases of infection is of major importance for
the definition of a TH1 or TH2 response (Scott 1991,
Scharton-Kersten & Scott 1995, Doherty & Coffman 1996,
Menon & Bretscher 1998). At this initial point,
characterization of the infected antigen presenting cell is
one of the fundamental aspects, since the interaction of
this cell with the lymphocyte will be the basis for the
development of the acquired immune response.
 In the haemorrhagic pool formed at the site of insect
bites (Fig. 2), parasite growth is mainly allowed by a
phagocytic cell – the monocyte, although it is not the
most abundant phagocyte. Neutrophils are short lived
cells present in higher numbers, but likely to play a major
role in parasite elimination instead of its hosting (Chang
1981). However, neutrophils may play other roles, such as
secreting cytokines like IL-12 and TGF-β (Tacchini-Cottier
et al. 2000) and may also present antigens via class II
MHC in the presence of GM-CSF (Gosselin et al. 1993). It
is possible that apoptotic infected neutrophils may yet
constitute an important initial source of Leishmania
antigen for dendritic cells (de Almeida 2002). Macrophages
are not present at the hemorrhagic pool and are scarce in
the normal, non-inflamed surrounding skin (Urmacher
1997). Mature epidermal dendritic cells may not be able to
ingest promastigotes (von Stebut et al. 1998, 2000), or do
it in a limited fashion (Konecny et al. 1999, Marovich et al.
2000), even when parasites are readily accessible, as in
case of excessive inocula (Lira et al. 2000). However, these
cells phagocytose and harbour amastigotes (von Stebut
et al. 1998). These findings may be explained by a
sequential model of infection with initial parasitism of
monocytes/macrophages and then of dendritic cells.
Fig. 2: illustration of phlebotomine feeding and promastigote
regurgitation in the dermal blood lake. The immunoadherence of
erythrocytes to promastigotes is shown with initial transference, at
left of the insect proboscide, of a promastigote to a monocyte and,
at the right to a neutrophil.  At the dermo-epidermial interface,
two Langerhans cells are bordering the blood lake at right of the
insect proboscide.  The drawing is not exactly in scale.  The cellular
elements are not in proportion, for example, neutrophils are ten
times more abundant than monocytes in human blood.
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Peripheral tissue immature dendritic cells could be from
epidermal origin (Langerhans cells), monocyte derived or
from other blood precursors (Mellman et al. 1998). These
cells are more endocytic than the mature dendritic cells
(Mellman et al. 1998). Consequently, these cells could
uptake apoptotic infected neutrophils, leishmania debris,
including genetic material, and in low numbers (2-3), the
parasite itself (Blank et al. 1993, Henri et al. 2002). Most
importantly, immature dendritic cells are exposed, at
peripheral sites, to a maturation stimulus that instruct them
to skin exodus (Mazzoni et al. 2001). At lymph node sites,
these cells will become highly competent APC cells.
Leishmania promastigotes, dead or alive, were shown to
inhibit dendritic cell motility (Jebbari et al. 2002).
Additionally, it has been found that chemokine receptor 2
(CCR2) deficiency is associated with impaired Langerhans
cell migration to the lymph node and deficiency, in the
lymph node, of TH1 priming CD8α- dendritic cells (Sato
et al. 2000). More than that, CCR2 gene knockout in L.
major resistant mice led to L. major susceptibility (Sato et
al. 2000). Could Leishmania, changing host cell patterns
of chemokine synthesis or chemokine receptors, intercept
the danger message in the way to the sentinel lymph node?
But, even if the migration occurs, the previous peripheral
micro-environment appears to determine, at the lymph
node, the future TH1/TH2 driving capacity of the mature
dendritic cells (Mazzoni et al. 2001). It has been shown,
for example, that histamine alters the polarizing capacity
of immature human monocyte derived dendritic cells, but
not its priming capacity, mainly due to the downregulation
of its IL-12 and IL-18 production (Mazzoni et al. 2001).
Prostaglandin E2, that can be elicited in the host by
components of insect saliva (Soares et al. 1998), was also
described to induce IL-12 deficient TH2 priming dendritic
cells (Kalinski et al. 1997). Besides these known host cell
elements and peripheral micro-environment substances,
other apparently secondary actors must be considered.
Mast cells, basophils and eosinophils could be present at
the initial phase of leishmania infection, in the tissue or in
the blood lake. Mast cells and basophils are both able to
produce histamine and cytokines, like IL-4, IL-10 and IL-
13 (Falcone et al. 2000, Mazzoni et al. 2001), which could
act on immature dendritic cells. Eosinophils have also been
described as cytokine producing APC cells (Weller & Lim
1997, Shi et al. 2000). Platelets, abundantly present in the
blood lake, could be another player. Dominguez and Torano
(2001) showed in vitro adherence between platelets and
promastigotes in mammals other than primates. From these
data, it is unlikely that platelets could have a direct action
on promastigotes in the human infection, and its role in
non-primate mammals is unknown. However, platelets were
described to interact directly with monocytes, inducing
monocyte secretion of monocyte chemotactic protein-1
and IL-8 (Weyrich et al. 1996). Thrombin stimulated
platelets cause superoxide anion generation by
neutrophils and monocytes (Nagata et al. 1993). Platelets
and mast cells have also been suggested to be a source of
CD40-Ligand involved in dendritic cell maturation (Lane
& Brocker 1999). Possible sources of platelet activation at
the initial phases of leishmania infection would be collagen
exposition by insect byte, thrombin generation due to
endothelial lesion, or endothelial/monocyte platelet
activating factor (Lonardoni et al. 2000). In vivo, the
potentially powerful platelet action is probably prevented
by insect saliva agents (see above). Nevertheless, it
remains a plausible hypothesis that platelets could have
a role as a host protecting agent in leishmaniasis.
Leishmaniasis occurs chiefly in tropical and sub-
tropical areas of the globe, where there is intense sun skin
exposition. Ultraviolet (UV) irradiation has intense effects
on skin immunology including: reduction in the density
and antigen presenting ability of Langerhans cells in the
epidermis (el-Ghorr & Norval 1997), increased Kera-
tinocyte secretion of IL-10 and prostaglandin E2, with
increased serum levels of IL-4 (Shreedhar et al. 1998),
induction of suppressive IL-12p40 homodimers by
dendritic cells and macrophages (Schmitt & Ullrich 2000).
Thus, UV irradiation seems to induce a resultant immu-
nosuppressive effect with decreased Th1 cell activation
and enhanced Th2 cell activation (Shreedhar et al. 1998).
This kind of microenvironment would be an ideal one for
Leishmania infection. Unexpectedly, it was found that
low dose UV irradiation, increasing serum and skin levels
of IFN-γ and TNF-α, conferred protection in murine
cutaneous leishmaniasis (Giannini 1986, Khaskhely et al.
2001, 2002). Whichever the way, we have here a im-
munomodulatory agent that could be of broad
epidemiological importance.
PARASITE’S GENERAL STRATEGY AT THE INITIAL
PHASES OF LEISHMANIA INFECTION
It is a maxim in microbiology that the higher the
infective inoculum the more the chance of the agent to
establish the infection. Paradoxically the natural infection
by Leishmania spp. does not use this law — the
phlebotomine regurgitates circa 100 (in a range of 1-1000)
metacyclics (Warburg & Schlein 1986). In spite of that,
several factors allow the parasite to infect host cells. First,
metacyclics are more resistant to complement lysis than
log phase promastigotes (Franke et al. 1985, Sacks &
Perkins 1985, Sacks 1989, Dominguez et al. 2002).
Additionally, it has been suggested that, metacyclics
interaction with serum complement could be different from
procyclic promastigotes (Puentes et al. 1988). Procyclic
cells would activate the alternative pathway whereas
metacyclics activate the classical pathway, even in the
absence of immune serum (Puentes et al. 1988). More
recently, however, other authors have confirmed previous
data (Mosser et al. 1986) that both complement pathways
are activated (Dominguez et al. 2002). Surprisingly, the C3
molecule binds in its active, lytic form, C3b, on the surface
metacyclic lipophosphoglican (LPG). The metacyclic
complement resistance is partly due to metacyclic LPG as
it has an increase in subunit numbers and a modification
in its sugar components which gives structurally a thicker
appearance to the parasite surface and hampers the C5-9
complex lytic pore formation (Puentes et al. 1990, Pimenta
et al. 1991, McConville et al. 1992). In addition, conversion
of C3b to C3bi could be happening through gp63
(Brittingham et al. 1995, Dominguez & Torano 1999) which
is much more expressed in metacyclic than procyclic
surface (Kweider et al. 1989, Ramamoorthy et al. 1992). In
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the absence of C3b mediated lysis the C3b coated
metacyclic will be more easily phagocytosed. The
complement resistance of metacyclics has been shown
indeed not to be absolute but a time dependent process
(Dominguez et al. 2002). IgM mediated immunoadherence
mechanisms (Mosser et al. 1986, Dominguez et al. 2002),
due to its very fast kinetics, permit the phagocitosis before
the complement  lyses all parasites (Dominguez & Torano
1999, Dominguez et al. 2002). Thus, even in low number,
the parasite is able to establish the infection. Once
inoculated, due to the initial conditions, it is predicted
that the parasite density will be very low, 0.03-0.1 parasite
per phagocyte (de Almeida 2002). This very low density,
instead of being a disadvantage, could lead to ignorance,
a previous unreported escape mechanism in leishmaniasis
(de Almeida 2002, de Almeida et al. 2003). Ignorance is
defined by the presence of functional T cells that are not
reactive to a given antigen (Abbas et al. 2000). However
when properly stimulated these cells could react and
proliferate in response to this antigen. On the other hand,
in anergy T cells become irreversibly unresponsive to the
antigen. Ignorance may be due to several factors: low
antigen concentration (Voehringer et al. 2000),
inappropriate antigen presentation by non professional
antigen presenting cells (APC), low number of reactive
cells, non activation of the APC (Shevach 1999), and
immunoprivileged sites (Kurts et al. 1999). Except for the
last condition, all these factors can be present at the initial
phases of Leishmania infection. It has also been recently
suggested that most molecules involved in host invasion
have been evolutionary selected for low immunogenicity
by long exposure to the host immune system, or are down
modulated after parasite invasion as seen with LPG and
gp63 (Chang et al. 2003).
What would be the advantages and disadvantages of
ignorance for Leishmania spp. infection? An obvious
disadvantage could be that when infecting in low number
the parasite could be destroyed by host innate immune
system before establishing the infection. However, as
previously commented, a series of ingenious mechanisms
due to insect saliva and the parasite itself permit its relative
success here. It is also a factor of success a ready access
to a permissive host cell, the monocyte (Chang et al. 1986,
2003). On the other hand, once internalyzed the parasite
could grow freely inside the permissive cell, eventually
changing the host microenvironment in parasite favour. It
has been demonstrated (Moore & Matlashewski 1994),
for example, that infection of bone marrow-derived mouse
macrophages (BMMs) by L. (L.) donovani promastigotes
or treatment of BMMs with LPG, inhibits macrophage
apoptosis. Another possible advantage would be the
inability to generate immunity by aborted attempts of
infection. On the other hand, once immunity is established
probably it will hamper reinfection.
What would be the biological constraints that may
lead the parasite to infect in such low numbers? There are
some evidences that excessive parasite growth could be
dangerous for the phlebotomine (Killick-Kendric 1987).
Besides that, excessive parasite growth would require
abundant nutrients, but its cycle in the insect gut lasts
days after the blood meal ingestion (Killick-Kendric 1987).
The sugars ingested by the insect, meanwhile, could
sustain differentiation but not parasite growth, as in vitro
experiments have shown (Schlein et al. 1987). Probably,
there is also a strong volumetric restriction to parasite
growth in anterior parts of the sand fly gut (Dominguez et
al. 2002). Finally, the insect proboscis, where metacyclics
are found prior to infection, is a starving place in the
insect gut, and usually it hosts no more than 10 meta-
cyclics (Killick-Kendric 1987).
Due to metacyclic time dependent serum complement
resistance, the parasite needs desperately to bind to its
host cell. This critical time in Leishmania’s life has been
estimated to be less than 2.5 min (Dominguez et al. 2002).
From the Leishmania point of view, if we could have it,
the complement aggression appears to be excessively
draconian. However, it could be viewed as a kind of rite
of passage. The complement aggression provides
Leishmania with the key molecules (C3b, C3bi) for
entrance, through the CR1, CR3 doors (Rosenthal et al.
1996) in the monocyte/macrophage sanctuary. The
binding of the parasite binding to CR3 (CD11b) could
induce suppression of the synthesis of IL-12, a main TH1
driving cytokine (Reiner et al. 1994, Marth & Kelsall 1997,
Sutterwala et al. 1997). Additionally, complement coated
parasites may have increased survival inside macrophage
(Mosser & Edelson 1987, Mosser & Brittingham 1997).
Within the macrophage the parasite has other strategies
for evading the host immunological system (Reiner 1994,
Reiner et al. 1994, Buates & Matlashewski 2001). One of
these strategies is the down modulation or not induction
of molecules involved directly or indirectly in antigen
presentation. For example L. (L.) donovani infection has
been shown to down modulate the expression of MHC I
and II molecules in human monocytes (Reiner et al. 1987).
We have also shown  that L. (L.) chagasi infected human
monocytes have a diminished HLA-DR expression. A
similar decrease is observed in IFN-γ stimulated HLA-DR
and HLA-ABC expression in infected human macrophages
(de Almeida et al. 2003).
Studies in mice are controversial, concerning the ability
of Leishmania infection to induce changes in the
expression pattern of costimulatory molecules of
monocyte/macrophage. No changes on costimulatory
molecules expression were found on macrophages from
the resistant C57BL/6 mice upon infection with L. (L.)
donovani (Saha et al. 1995) or with L. (L.) major (von
Stebut et al. 1998). L. (L.) donovani infection of macro-
phages from susceptible BALB/c mice marginally
increases CD54 (Saha et al. 1995) but fails to trigger CD80
(Kaye et al. 1994). L. (L.) major was also not able to change
the low level of CD80 expression and the basal level of
CD86 expression in human macrophages (Brodskyn et al.
2001). The pattern of expression of costimulatory
molecules has been implicated in driving the immune
system to a TH1 or a TH2 response leading to secretion
of cytokines that could activate the macrophage and arrest
the infection or burst it (Kaye 1995, Hunter & Reiner 2000).
A direct relationship between costimulatory molecules,
particularly CD80 and CD86, and a TH1 or TH2 response
in established leishmaniasis models is not clear (Murphy
et al. 1997, Hunter & Reiner 2000). Blockage of CD86
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reduced parasitism in BALB/c mice (with a predominant
TH2 response), implicating CD86 in production of TH2
cytokines and disease induction (Brown et al. 1996,
Tsuyuki et al. 1997). In contrast blocking CD86 in cultures
of L. (L.) major-infected human macrophages plus
peripheral blood lymphocytes lead to a significant
inhibition of IFN-γ production (Brodskyn et al. 2001), a
classical TH1 cytokine. An apparent contrary result was
also obtained in L. (L.) donovani model of visceral
leishmaniasis where CD86 blocking increased IFN-γ
production and reduced parasite burden (Murphy et al.
1997). A possible explanation for these results is that a
more complex picture could be involved in driving
lymphocytes to TH1 or TH2 response (Kim et al. 1999).
Whereas CD80 or CD86 expression leads to high IL-4 and
IL-10 production by naive CD4 T cells, co-expression of
CD54 plus CD80 or CD 86 resulted in decreased IL-4 and
IL-10 production (Luksch et al. 1999). Additionally, co-
stimulation by CD80 and CD54, but not by CD80 or CD54
alone, leads to rapid TNF-α cytotoxicity, tumor rejection
and generation of memory T cells (Nishio & Podack 1996).
Moreover, both B7 and CD54 may co-regulate activation-
driven maturation of T cells (Damle et al. 1992). We have
found (de Almeida et al. 2003) that L. (L.) chagasi infection
does not induce CD54 expression in human monocytes or
macrophages, and a negative correlation was observed
between CD54 and CD86 expression. It is possible that
avoidance of simultaneous expression of these two
molecules and consequently impaired costimulatory
activity is a escape mechanism exploited by L. (L.) chagasi.
Whichever explanation is given, however, it has to be viewed
with criticism mainly due to increasing number of
costimulatory molecules that have been reported (Sharpe
& Freeman 2002) and the consequently ignored interactions
or combinations of effects among these molecules.
Recently it has been shown (Buates & Matlashewski
2001) that L. (L.) donovani infection leads to down
modulation of aproximately 40% of a large number of tested
genes in mice macrophages, including genes of NFkβ
family, which are involved in inflammation and immunity.
Leishmania infection does not induce TNF-α or IL-12
production in human monocytes (Reiner et al. 1990, Ghalib
et al. 1995, Sartori et al. 1997) or macrophages but inhibits
IL-12 production by LPS-stimulated monocytes. In
addition, we have shown (de Almeida et al. 2003) that
some striking inhibitory effects, as for CD54 expression
or IL-12, were only observed if the infected cells were
challenged with an inflammatory stimulus, LPS. Indeed,
some reports (von Stebut et al. 1998, Marovich et al. 2000)
had not identified changes in the pattern of costimulatory
molecules, MHC class II and basal level of cytokine
production in infected macrophages. It is surprising that
the parasite induces few changes or no changes at all in
the resting host cell. These reinforces the possibility of
ignorance at most initial steps of Leishmania spp.
infection. Ignorance would be broken by improper
operation of down regulatory mechanisms, or when the
parasite or its antigens reach highly competent dendritic
cells (Gorak et al. 1998, von Stebut et al. 1998, Marovich et
al. 2000), due to parasite multiplication in the initial
permissive host cells.
MAN AND MICE
Although the murine model is the most frequently
employed for the study of Leishmania infections, it
presents a series of important differences in relation to
the human disease that limit the possibility of
extrapolations. Nevertheless, the application of this model
is still essential for the study of human leishmaniasis,
insofar as ethic imperatives hamper the analysis of many
aspects of the human disease, making in vitro and in vivo
studies necessary. In mice, for example, leishmaniasis does
not reproduce the mucosal and visceral forms observed
in humans. The clear involvement of nitric oxide (NO) in
intracellular parasite elimination and the clear-cut
predominance of TH1 and TH2 responses related to
resistance or susceptibility observed in mice are not seen
in humans (Stenger et al. 1996). In spite of the mentioned
limitations of the mice model, recent observations using
inocula similar to those of the natural infection achieved
success in generating asymptomatic, and subclinical states
with a pattern of T helper response similar to that found in
man (Belkaid et al. 2001, Uzonna et al. 2001). Surprisingly,
higher inocula (~106) of parasites induce a skewed TH1
response in resistant mice and a TH2 response in
susceptible mice, while inocula similar to the natural
infection (~102) induce a mixed TH1/TH2 response in both
resistant and susceptible mice (Uzonna & Bretscher 2001,
Uzonna et al. 2001). There is also a strong evidence of
parasite clearance by a skewed TH1 response in
susceptible mice (Uzonna et al. 2001). Also important are
the observations that immunity can be achieved and lost
in asymptomatic mice, being maintened in a subclinical
status by persistent low parasite numbers (Uzonna et al.
2001). Similar results have been obtained for resistant mice,
in which a TH2 response is necessary to maintain the
subclinical state (Belkaid et al. 2001). Unexpectedly, the
possibility of parasite retransmission to its vector is higher
with a low inoculum, similar to a natural one, inducing
subclinical states. Thus the evolutionary mechanisms
apparently select for the optimal condition that gives the
best chances of infection and retransmission by a host,
unknown a priori, if resistant or susceptible, maintaining
the parasite cycle.
GENERAL COMMENTS
The main driving force leading to increasing com-
prehension of the initial steps in leishmaniasis is the man
possession of strategies that avoid parasite infection. The
strategy that best fit this goal appears to be a vaccine. In
this respect, the results obtained focusing in initial steps
has led to new promising results obtained using insect
salivary peptides and low dose inocula in mice. The
eliciting of antibodies or other strategies that retard
parasite phagocytose could be also a logical step, as
metacyclic serum resistance is a time dependent process.
More immediate and practical results have emerged in the
potential use of salivary peptides in epidemiological
studies. Besides that, we could be taught by insect and
parasite new strategies for avoiding inflammation and
coagulation.
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